Table 1 Description of HCV drug regimens prescribed for 12 weeks (23 patients) or for 24 weeks (26 patients).

From: HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection

Anti-HCV treatment

12-week regimen (23 patients)

24-week regimen (26 patients)

OMV + PAR + DBV

1 (4.3)

0

OMV + PAR + DBV + RBV

7 (30.4)

5 (19.2)

DAC + SOF

1 (4.3)

0

LDV + SOF

6 (26.1)

6 (23.1)

LDV + SOF + RBV

7 (30.4)

3 (11.5)

SOF + RBV

1 (4.3)

0

OMV + PAR + RBV

0

3 (11.5)

DAC + SOF + RBV

0

9 (34.6)

  1. Data are expressed as absolute number and percentage (respect to the number of subjects included in the regimen).
  2. OMV ritonavir boosted ombitasvir, PAR paritaprevir, DBV dasabuvir, RBV ribavirin, DAC daclatasvir, LDV ledipasvir, SOF sofosbuvir.
Back to article page